These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 24329534)

  • 1. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Reactive Antibodies to the NS1 Protein of Omsk Hemorrhagic Fever Virus Are Absent in the Sera of Patients with Tick-Borne Encephalitis.
    Kravchuk BI; Khlusevich YA; Chicherina GS; Yakimenko VV; Krasnova EI; Tikunova NN; Matveev AL
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
    Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
    Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.
    Pripuzova NS; Gmyl LV; Romanova LIu; Tereshkina NV; Rogova YV; Terekhina LL; Kozlovskaya LI; Vorovitch MF; Grishina KG; Timofeev AV; Karganova GG
    PLoS One; 2013; 8(4):e61094. PubMed ID: 23585873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus.
    Morozova OV; Bakhvalova VN; Potapova OF; Grishechkin AE; Isaeva EI; Aldarov KV; Klinov DV; Vorovich MF
    Vaccine; 2014 May; 32(25):3101-6. PubMed ID: 24631082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes.
    Fritz R; Orlinger KK; Hofmeister Y; Janecki K; Traweger A; Perez-Burgos L; Barrett PN; Kreil TR
    Vaccine; 2012 Feb; 30(6):1165-9. PubMed ID: 22178103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination.
    Remoli ME; Marchi A; Fortuna C; Benedetti E; Minelli G; Fiorentini C; Mel R; Venturi G; Ciufolini MG
    Pathog Dis; 2015 Mar; 73(2):1-3. PubMed ID: 25722483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.
    Yoshii K; Sunden Y; Yokozawa K; Igarashi M; Kariwa H; Holbrook MR; Takashima I
    J Virol; 2014 May; 88(10):5406-20. PubMed ID: 24574402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Salát J; Formanová P; Huňady M; Eyer L; Palus M; Ruzek D
    Vaccine; 2018 Nov; 36(48):7257-7261. PubMed ID: 30337175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.
    Omori-Urabe Y; Yoshii K; Ikawa-Yoshida A; Kariwa H; Takashima I
    Microbiol Immunol; 2011 Dec; 55(12):893-7. PubMed ID: 22004565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tick-borne encephalitis.
    Gritsun TS; Lashkevich VA; Gould EA
    Antiviral Res; 2003 Jan; 57(1-2):129-46. PubMed ID: 12615309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant subolesin does not reduce tick infection with tick-borne encephalitis virus nor protect mice against disease.
    Havlíková S; Ličková M; Ayllón N; Roller L; Kazimírová M; Slovák M; Moreno-Cid JA; Pérez de la Lastra JM; Klempa B; de la Fuente J
    Vaccine; 2013 Mar; 31(12):1582-9. PubMed ID: 23357197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.